We are live on ! Find out more
SIC

Salem Investment Counselors Portfolio holdings

AUM $4.03B
1-Year Est. Return 61.49%
This Fund
S&P 500
This Quarter Est. Return
+8.74%
1 Year Est. Return
+61.49%
3 Year Est. Return
+158.64%
5 Year Est. Return
+203.54%
10 Year Est. Return
+1,118.52%
AUM
$2.5B
AUM Growth
+$160M
Cap. Flow
+$16M
Cap. Flow %
0.64%
Top 10 Hldgs %
52.14%
Holding
1,174
New
78
Increased
218
Reduced
240
Closed
56

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$5.57M
2
SRDX
Surmodics
SRDX
+$3.31M
3
NEM icon
Newmont
NEM
+$2.75M
4
CAT icon
Caterpillar
CAT
+$2.69M
5
TSM icon
TSMC
TSM
+$2.52M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 34.99%
2 Technology 20.92%
3 Healthcare 8.38%
4 Financials 7.98%
5 Consumer Staples 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BOLT icon
1101
Bolt Biotherapeutics
BOLT
$6.63M
$56 ﹤0.01%
2
HOOK
1102
DELISTED
HOOKIPA Pharma
HOOK
$56 ﹤0.01%
8
SNY icon
1103
Sanofi
SNY
$105B
$55 ﹤0.01%
1
TCRR
1104
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$53 ﹤0.01%
35
OUSTZ
1105
DELISTED
Ouster Inc Warrants
OUSTZ
$30 ﹤0.01%
250
TMQ
1106
Trilogy Metals
TMQ
$650M
$27 ﹤0.01%
50
YALA
1107
Yalla Group
YALA
$821M
$20 ﹤0.01%
5
BYND icon
1108
Beyond Meat
BYND
$214M
$17 ﹤0.01%
1
PTN
1109
Palatin Technologies
PTN
$16.8M
0
TTCF
1110
DELISTED
Tattooed Chef, Inc Class A Common Stock
TTCF
$15 ﹤0.01%
10
CDXS icon
1111
Codexis
CDXS
$175M
$13 ﹤0.01%
3
MOMO
1112
Hello Group
MOMO
$867M
$10 ﹤0.01%
1
CDAK
1113
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$9 ﹤0.01%
50
BYD icon
1114
Boyd Gaming
BYD
$6.03B
0
YTEN
1115
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
0
SDC
1116
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$3 ﹤0.01%
5
EAD
1117
Allspring Income Opportunities Fund
EAD
$379M
-21
Closed -$138
TOPS icon
1118
TOP Ships
TOPS
$4.33M
0
ACB
1119
Aurora Cannabis
ACB
$237M
-80
Closed -$738
ADNT icon
1120
Adient
ADNT
$1.44B
-8
Closed -$278
BC icon
1121
Brunswick
BC
$5.21B
-50
Closed -$3.6K
BNTX icon
1122
BioNTech
BNTX
$23.3B
-20
Closed -$3K
BVS icon
1123
Bioventus
BVS
$1.17B
-14,375
Closed -$37.5K
CBRL icon
1124
Cracker Barrel
CBRL
$1.31B
-250
Closed -$23.7K
CEG icon
1125
Constellation Energy
CEG
$98.7B
-29
Closed -$2.5K

Similar funds

Salem Investment Counselors's Q1 2023 Portfolio in Review

As of Q1 2023, Salem Investment Counselors held 1,174 positions worth $2.5B, up 6.8% from $2.34B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Salem Investment Counselors's Q1 2023 filing shows 78 new, 218 increased, 240 reduced and 56 closed positions. Its largest new stake was Surmodics: 128,475 shares worth $2.93M. The largest sale was Avantor, an estimated $3.65M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, down from 36% a quarter earlier, followed by Technology and Healthcare.

  • Salem Investment Counselors's largest Q1 2023 buy was Surmodics: 128,475 shares worth $2.93M.
  • Salem Investment Counselors added most to Thermo Fisher Scientific in Q1 2023, an estimated $5.57M increase.
  • Salem Investment Counselors's biggest Q1 2023 reduction was Avantor, cutting an estimated $3.65M.
  • Salem Investment Counselors fully exited SVB Financial Group in Q1 2023, selling an estimated $551K.
  • Salem Investment Counselors's ten largest holdings make up 52% of its $2.5B portfolio in Q1 2023.
  • Salem Investment Counselors opened 78 new positions and closed 56 in Q1 2023.
  • Salem Investment Counselors's portfolio value rose 6.8% quarter-over-quarter to $2.5B.

Based on Salem Investment Counselors's 13F filing for Q1 2023, filed 11 May 2023.